Navigation Links
Neurocrine Biosciences Reports First Quarter 2012 Results
Date:5/2/2012

is study assessed once-daily NBI-98854 (12.5mg or 50mg) over a two-week dosing period in 37 randomized subjects. Based on the positive outcome of this study the Company is planning to launch a large Phase IIb trial in mid-2012. This placebo controlled, double-blind, parallel design, multiple dose, twelve week study will assess six-week dosing of NBI-98854, against placebo, followed by six weeks of active treatment with NBI-98854. The study will incorporate a capsule formulation of NBI-98854.

In January of 2012, the Company was notified that the FDA Division of Psychiatry Products had granted Fast Track status to NBI-98854 for neuroleptic-induced tardive dyskinesia. The FDA's Fast Track program is designed to facilitate the development and expedite the review of drugs intended to treat serious diseases and address unmet medical needs.

Urocortin 2 Update
The Christchurch Cardioendocrine Research Group at University of Otago, Christchurch School of Medicine and Health Sciences, New Zealand, in collaboration with the Company, is conducting a Phase II study of urocortin 2 in acute decompensated heart failure patients. This study is now complete and top-line results are expected shortly.

The Company has completed several Phase I studies and two Phase II studies of urocortin 2 in patients with stable congestive heart failure. These Phase II studies showed urocortin 2 to be well tolerated with positive hemodynamic effects as evidenced by increases in cardiac output and efficiency.

Conference Call and Webcast Today at 5:00PM Eastern Time
Neurocrine will hold a live conference call and webcast today at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Participants can access the live conference call by dialing 800-894-5910 (US) or 785-424-1052 (International) using the conference ID: NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com<
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
2. Neurocrine Biosciences Reports First Quarter 2008 Results
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
5. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
6. Neurocrine Biosciences Presents Elagolix Data
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2009 Results
9. Neurocrine Advances VMAT2 Inhibitor Program
10. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
11. Neurocrine Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... HARRISON, N.Y. , May 22, 2013  MGT ... the Company will present at the Second Annual Marcum ... New York City at the ... President and Chief Executive Officer, will update investors and ... The Company,s presentation is scheduled to begin ...
(Date:5/22/2013)... 2013 Hemoglobin A1C levels increased over ... 2 diabetes, while modest improvements in A1C control ... can lead to substantial healthcare cost savings, according ... for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual ... by Valeritas, makers of the V-Go ® ...
(Date:5/22/2013)... Ohio , May 22, 2013   Life ... health screening services announced today the creation of a ... (MCM) . MCM is a population ... to MCM,s growing list of clients. These important expanded ... costly chronic conditions earlier. Effective prevention reduces cost of ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... Scientific Corporation,s (NYSE: BSX ) Board of ... of up to $1.0 billion of its common stock ... an existing share repurchase program. "This repurchase ... Company,s long-term business prospects, earnings growth potential and our ...
... PALM BEACH, Fla., July 28, 2011 China Nuvo ... that SurgLine, Inc. has executed a stocking distribution agreement with ... distributor of orthopedic, spine and ENT products selling into hospitals ... of OptiMedical stated, "We are excited and look forward to ...
Cached Medicine Technology:Boston Scientific Announces $1.0B Share Repurchase Program 2Boston Scientific Announces $1.0B Share Repurchase Program 3China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp. 2China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp. 3
(Date:5/22/2013)... (PRWEB) May 22, 2013 Homeopathic Vibes is ... cannot make it to the store during normal hours. On ... “The change is to accommodate some of our patients who ... the day time or on Saturdays,” says owner and homeopathic ... 10 a.m. to 6 p.m. Monday through Friday; weekends are ...
(Date:5/22/2013)... with heart failure are more likely to experience poorer ... mildly underactive, according to a new study. ... risk of death linked to the condition, which is ... first to show that African-Americans who have hypothyroidism face ... racial and ethnic groups," Dr. Connie Rhee, of Brigham ...
(Date:5/22/2013)... of internal medicine residents at Massachusetts General Hospital (MGH) ... found that more than half rated the training they ... as fair or poor. Significant numbers felt unprepared to ... of practicing physicians. In response to the findings, recently ... the MGH has increased residents, training in addiction medicine. ...
(Date:5/22/2013)... of up to 1,000 mg per day can help ... author was Lisa Langsetmo, a Ph.D. Research Associate at ... Goltzman, Division of Endocrinology and Metabolism in the Department ... in the Musculoskeletal Disorders axis at the Research Institute ... published in the Journal of Clinical Endocrinology & ...
(Date:5/22/2013)... that make energy to keep cells alive is a ... drug-resistant forms of cancer source of a serious ... a new study published in the journal ACS ... explain that doxorubicin and other common forms of chemotherapy ... cancer cells. Cancer cells divide and multiply faster than ...
Breaking Medicine News(10 mins):Health News:Homeopathic Vibes Now Open Late on Wednesdays 2Health News:Underactive Thyroid and Heart Failure a Bad Combination: Study 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Calcium supplements linked to longer lifespans in women 2
... man, who tested negative for the human form of the ... Diseases, in Bucharest// , after he exhibited flu like symptoms. ... H5N1 had infected the birds in the area. ... Bucharest national laboratory. The Ministry of Health has designated the ...
... rising obesity rates by 2010 will fall flat on its face, ... to a recent study// . Though local level work is going ... about the thrust given to this area. The public Health Minister, ... lots left to be done. Obesity has sent the NHS expenditure ...
... and Research Institutes, Inc (NDRI) in New York ... explored the role// of social supports, spirituality, religiousness, ... of recovery from addiction. The study reveals markedly ... as a decrease in stress when people were ...
... A 91-year-old woman in British Columbia died a lonely death after ... sons, is hopeful that his mom’s death// will bring about some ... ,The hospital separated Fanny Albo from her ailing husband who ... in Trail. Fanny Albo and her husband had been together for ...
... to a new Japanese study appearing in the current ... green tea daily may help reduce risk of dementia,.// ... related with the risk of having cognitive impairment in ... , Dr. Shinichi Kuriyama of Tohoku University Graduate ...
... Germany has reported that regular peelings and scrubbing with a ... the skin is stretched during pregnancy. // ,Peelings and ... magazine said. The same is true of massages. ... use of certain substances can help. ...
Cached Medicine News:Health News:Drug Addiction Recovery Buffered by Spirituality 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: